HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fabiana Alves Selected Research

Biomarkers (Surrogate Marker)

1/2020Urine-based antigen detection assay for diagnosis of visceral leishmaniasis using monoclonal antibodies specific for six protein biomarkers of Leishmania infantum / Leishmania donovani.
1/2019Development of a Multiplexed Assay for Detection of Leishmania donovani and Leishmania infantum Protein Biomarkers in Urine Samples of Patients with Visceral Leishmaniasis.
1/2018Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fabiana Alves Research Topics

Disease

27Visceral Leishmaniasis (Kala Azar)
05/2024 - 01/2015
6Leishmaniasis
05/2024 - 01/2020
4Infections
01/2020 - 06/2011
3Chagas Disease (American Trypanosomiasis)
01/2023 - 01/2018
2Cardiotoxicity
01/2023 - 10/2018
2Neglected Diseases
11/2022 - 08/2022
2Myositis Ossificans (Fibrodysplasia Ossificans Progressiva)
08/2021 - 02/2019
1Nausea
11/2023
1Vomiting
11/2023
1Drug-Related Side Effects and Adverse Reactions
11/2023
1Tuberculosis (Tuberculoses)
10/2022
1Parasitic Diseases (Parasitic Disease)
01/2022
1Maternal Death
01/2021
1Spontaneous Abortion (Miscarriage)
01/2021
1Stillbirth
01/2021
1Asymptomatic Diseases
01/2020
1Renal Insufficiency (Renal Failure)
01/2019
1Cutaneous Leishmaniasis
01/2018
1Hypertrophy
01/2018
1Cardiovascular Diseases (Cardiovascular Disease)
04/2013
1Human Influenza (Influenza)
03/2013
1Virus Diseases (Viral Diseases)
06/2011
1Schistosomiasis mansoni
06/2011
1Schistosomiasis (Bilharziasis)
06/2011

Drug/Important Bio-Agent (IBA)

15miltefosine (Impavido)IBA
05/2024 - 01/2016
9Paromomycin (Paromomycin Sulfate)FDA LinkGeneric
11/2023 - 03/2017
9liposomal amphotericin BFDA Link
11/2023 - 01/2016
4Antimony Sodium Gluconate (Sodium, Stibogluconate)IBA
01/2023 - 01/2016
3Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2018
3Pentamidine (NebuPent)FDA LinkGeneric
01/2019 - 01/2015
2benzonidazole (benznidazole)IBA
01/2023 - 01/2018
2Amphotericin B (Amphotericin)FDA LinkGeneric
08/2022 - 01/2018
2Propranolol (Inderal)FDA LinkGeneric
08/2021 - 02/2019
2Ascorbic Acid (Vitamin C)FDA LinkGeneric
08/2021 - 02/2019
2AntigensIBA
01/2020 - 01/2020
2Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2019
2alamandineIBA
01/2018 - 04/2013
1AminoglycosidesIBA
11/2022
1Antiparasitic Agents (Antiparasitics)IBA
08/2022
1Indicators and Reagents (Reagents)IBA
01/2020
1Monoclonal AntibodiesIBA
01/2020
1ElementsIBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1ProdrugsIBA
01/2018
1Angiotensin IIIBA
01/2018
1NeopterinIBA
01/2018
1ER 30346 (ravuconazole)IBA
01/2018
1Anti-Bacterial Agents (Antibiotics)IBA
01/2014
1AntibodiesIBA
03/2013
1Caspase 3 (Caspase-3)IBA
06/2011
1Messenger RNA (mRNA)IBA
06/2011
1Caspase 8 (Caspase-8)IBA
06/2011
1Viral ProteinsIBA
06/2011
1Praziquantel (Biltricide)FDA Link
06/2011

Therapy/Procedure

5Therapeutics
11/2023 - 01/2014
1Blood Transfusion (Blood Transfusions)
05/2024
1Aftercare (After-Treatment)
04/2024
1Duration of Therapy
01/2023
1Patient Admission (Patient Admissions)
01/2019
1Injections
10/2018